AI assistant
abrdn Asia Focus plc — Director's Dealing 2019
Apr 1, 2019
4745_dirs_2019-04-01_a21d4908-c2c6-4d7e-ab7e-39a35dd5628d.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7319U
Aberdeen Standard Asia Focus PLC
01 April 2019
ABERDEEN STANDARD ASIA FOCUS PLC
Legal Entity Identifier (LEI): 5493000FBZP1J92OQY70
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
MS CHARLOTTE BLACK
2
Reason for the notification
a)
Position/status
NON EXECUTIVE DIRECTOR
b)
Initial notification/ Amendment
INITIAL NOTIFICATION
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
ABERDEEN STANDARD ASIA FOCUS PLC
b)
LEI
5493000FBZP1J92OQY70
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
ORDINARY 25P SHARES
GB0000100767
b)
Nature of the transaction
SHARE PURCHASE
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £10.46 | 958 |
d)
Aggregated information
- Aggregated volume
- Price
958 ORDINARY SHARES OF 25P EACH
£10,020.68 TOTAL PRICE
e)
Date of the transaction
2019-04-01
f)
Place of the transaction
LONDON STOCK EXCHANGE, MAIN MARKET (XLON)
Following this transaction the total beneficial Interest for MS CHARLOTTE BLACK is 958 Ordinary 25p Shares
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBSGDSCUGBGCB